Acid Reflux Drug Kidney Injury Lawyers: Reviewing Claims for Nexium, Prilosec, Other PPIs
October 2023 Update: Following an October 2023 PPI heartburn drug lawsuit settlement, Saiontz & Kirk, P.A. is no longer reviewing new potential cases. The information on this page is for informational purposes only.
The product liability lawyers at Saiontz & Kirk, P.A. previously investigated potential Nexium lawsuits, Prilosec lawsuits and other acid reflux drug lawsuits for users of popular proton pump inhibitors (PPI) who were diagnosed with:
- Acute Kidney Injury or Interstitial Nephritis
- Chronic Kidney Disease
- Kidney Failure, Dialysis Treatment or Kidney Transplant
Proton pump inhibitors (PPI) are a popular class of heartburn and acid reflux drug, which have been used by millions of Americans.
Although they are marketed as safe and effective, it appears that the drug makers may have failed to adequately warn about the link between side effects of acid reflux drugs and kidney problems, including acute kidney injury, acute interstitial nephritis, chronic kidney disease and renal failure.
Potential claims were previously reviewed by the kidney injury lawyers at Saiontz & Kirk, P.A. to determine if financial compensation was available as a result of the drug makers’ apparent decision to place their desire for profits before consumer safety.
Many of our clients claimed that if stronger warnings about the acid reflux drug kidney risks had been provided to consumers and medical providers, many individuals may have been able to avoid this serious injury by limiting use of the drugs, discontinuing after severe episodes of acid reflux or heartburn are over, or pursuing alternative treatments, such as life-style changes.
All acid reflux drug kidney injury cases were pursued by our lawyers under a contingency fee agreement, which means that there are never any up-front costs associated with hiring our law firm.
New proton pump inhibitor (PPI) cases are no longer being investigated by Saiontz & Kirk, P.A. The content on this page is for informational purposes only.